Cargando…
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
BACKGROUND: The chromodomain, helicase DNA-binding protein 5 (CHD5) is a potential tumor suppressor gene located on chromosome 1p36, a region recurrently deleted in high risk neuroblastoma (NB). Previous data have shown that CHD5 mRNA is present in normal neural tissues and in low risk NB, neverthel...
Autores principales: | Garcia, Idoia, Mayol, Gemma, Rodríguez, Eva, Suñol, Mariona, Gershon, Timothy R, Ríos, José, Cheung, Nai-Kong V, Kieran, Mark W, George, Rani E, Perez-Atayde, Antonio R, Casala, Carla, Galván, Patricia, de Torres, Carmen, Mora, Jaume, Lavarino, Cinzia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992029/ https://www.ncbi.nlm.nih.gov/pubmed/20950435 http://dx.doi.org/10.1186/1476-4598-9-277 |
Ejemplares similares
-
DNA Hypomethylation Affects Cancer-Related Biological Functions and Genes Relevant in Neuroblastoma Pathogenesis
por: Mayol, Gemma, et al.
Publicado: (2012) -
Polymorphisms in the Calcium-Sensing Receptor Gene Are Associated with Clinical Outcome of Neuroblastoma
por: Masvidal, Laia, et al.
Publicado: (2013) -
Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens
por: Rodríguez-Hernández, Carlos J., et al.
Publicado: (2016) -
Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma
por: Lavarino, Cinzia, et al.
Publicado: (2009) -
DNA methylation fingerprint of neuroblastoma reveals new biological and clinical insights
por: Gómez, Soledad, et al.
Publicado: (2015)